Recent News

• 03.31.2025 - Traws Pharma Reports Full Year 2024 Results and Business Highlights
• 03.31.2025 - Traws Pharma Reports Full Year 2024 Results and Business Highlights
• 03.28.2025 - Traws Pharma Announces Management Updates
• 03.28.2025 - Traws Pharma Announces Management Updates
• 03.26.2025 - Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET
• 03.26.2025 - Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET
• 03.25.2025 - Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR
• 03.25.2025 - Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR
• 03.24.2025 - Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates
• 03.24.2025 - Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates

Recent Filings

• 03.31.2025 - 8-K Current report
• 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.31.2025 - EX-99.1 EX-99.1
• 03.28.2025 - 8-K Current report
• 03.28.2025 - EX-99.1 EX-99.1
• 03.25.2025 - EX-99.1 EX-99.1
• 03.25.2025 - 8-K Current report
• 03.24.2025 - 8-K Current report
• 03.24.2025 - EX-99.1 EX-99.1